Filing Details

Accession Number:
0001136261-22-000247
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-27 16:29:17
Reporting Period:
2022-05-26
Accepted Time:
2022-05-27 16:29:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1017491 Seelos Therapeutics Inc. SEEL Pharmaceutical Preparations (2834) 870449967
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1208853 Margaret Dalesandro C/O Seelos Therapeutics, Inc.
300 Park Avenue, 2Nd Floor
New York NY 10022
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-26 35,000 $0.60 35,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average purchase price. These shares were acquired in multiple open market transactions at prices ranging from $0.5939 per share to $0.60 per share, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price.